FDA and Parenteral Drug Association (PDA) will host the 33rd Joint Regulatory Conference to emphasize the role of effective quality systems in ensuring an ongoing state of control throughout the product lifecycle.

The conference will:

• focus on the vital role of robust quality systems, facilities, processes, raw material quality, supplier relationships, industrial modernization and quality risk management, which are fundamental to current good manufacturing practice (CGMP) compliance
• include case studies to provide practical insights and illustrate how sustainable compliance establishes the foundation for quality and supply consistency
• highlight international collaboration efforts that improve quality and benefit consumers